Liquid Droplets Inside Cancer Cells Explain Why a Leukemia Drug Works So Slowly
A new Cell Research study shows that BCR-ABL1 forms liquid-like phase-separated condensates inside leukemic cells that physically slow tyrosine kinase ...
A new Cell Research study shows that BCR-ABL1 forms liquid-like phase-separated condensates inside leukemic cells that physically slow tyrosine kinase ...
A large Japanese multicenter cohort study finds that patients with metastatic gastrointestinal stromal tumors survive significantly longer when metastases appear ...
Researchers at the University of São Paulo used a qPCR-based gene expression panel to divide canine splenic hemangiosarcoma into three ...
For decades, the pharmaceutical industry’s most familiar strategy for extending the commercial life of a successful medicine has been to ...
Intrinsic drug resistance remains one of the formidable challenges in cancer therapy, often thwarting the efficacy of promising treatments and ...
In a groundbreaking study poised to reshape therapeutic strategies for hepatocellular carcinoma (HCC), researchers have demonstrated the superior efficacy and ...
Ewing’s sarcoma (ES) stands as one of the most aggressive primary bone malignancies, predominantly afflicting children and adolescents. This rare ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine